128
Participants
Start Date
May 5, 2024
Primary Completion Date
May 5, 2026
Study Completion Date
November 5, 2026
Deucravacitinib
Throughout the study, there will be a total of six visits conducted: selection, inclusion, Week 12, Week 24, Week 36, and Week 48. In patients who volunteer, a skin biopsy will be performed on both the lesional and peri-lesional areas at baseline, Week 12 and Week 36. Serum and plasma samples will be collected at the screening visit, Week 12, Week 24, Week 36, and Week 48.
Volunteer without treatment
Throughout the study, there will be a total of six visits conducted: selection, inclusion, Week 12, Week 24, Week 36, and Week 48. In patients who volunteer, a skin biopsy will be performed on both the lesional and peri-lesional areas at baseline, Week 12 and Week 36. Serum and plasma samples will be collected at the screening visit, Week 12, Week 24, Week 36, and Week 48.
RECRUITING
CHU de Bordeaux, Bordeaux
RECRUITING
CHU de Nice - Hôpital de l'Archet, Nice
RECRUITING
APHP, Henri Mondor, Paris
RECRUITING
CHU de Lille, Lille
RECRUITING
HCL, Lyon
Centre Hospitalier Universitaire de Nice
OTHER